TAIPEI, March 17, 2025 /PRNewswire/ -- Microbio Co., Ltd. (TPEx: 4128) today announced promising results from an exploratory clinical trial assessing MS-20 in combination with current medications for ...
Microbio (4128) has delivered a -40.53% change over the past year, with a 52-week range between 14.55 and 30.30. What Is the Average Daily Trading Volume of Microbio (4128)? The average daily trading ...
Visit a quote page and your recently viewed tickers will be displayed here.
BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, today announced that is has signed a worldwide exclusive licensing agreement with Oneness Biotech (Taiwan, ...
Leo Pharma is paying $40 million upfront and $530 million in biobucks to license a midstage experimental eczema and asthma drug. The therapy, FB825, has been developed by Oneness Biotech and Microbio ...
CUPERTINO, Calif., Dec. 16, 2024 /PRNewswire/ -- Microbio Co., Ltd. (4128) today revealed encouraging results from an exploratory clinical trial of MS-20 combined with Keytruda (pembrolizumab) in ...
Microbio has developed a pathogen test to help identify “a silent killer” that is notoriously difficult to predict, diagnose and treat. Brisbane medtech scale-up Microbio has developed a game-changing ...
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer ...
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer ...
4147.TWO TaiMed Biologics Inc.
Visit a quote page and your recently viewed tickers will be displayed here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results